Literature DB >> 23654212

Associations between arterial stiffness and platelet activation in normotensive overweight and obese young adults.

Jennifer N Cooper1, Rhobert W Evans, Maria Mori Brooks, Linda Fried, Chris Holmes, Emma Barinas-Mitchell, Kim Sutton-Tyrrell.   

Abstract

Obese individuals have elevated platelet activation and arterial stiffness, but the strength and temporality of the relationship between these factors remain unclear. We aimed to determine the effect of increased arterial stiffness on circulating platelet activity in overweight/obese young adults. This analysis included 92 participants (mean age 40 years, 60 women) in the Slow Adverse Vascular Effects of excess weight (SAVE) trial, a clinical trial examining the effects of a lifestyle intervention with or without sodium restriction on vascular health in normotensive overweight/obese young adults. Carotid-femoral (cf), brachial-ankle (ba) and femoral-ankle (fa) pulse wave velocity (PWV) served as measures of arterial stiffness and were measured at baseline and 6, 12 and 24 months follow-up. Platelet activity was measured as plasma β-thromboglobulin (β-TG) at 24 months. Higher plasma β-TG was correlated with greater exposure to elevated cfPWV (p = 0.02) and baPWV (p = 0.04) during the preceding two years. After adjustment for serum leptin, greater exposure to elevated baPWV remained significant (p = 0.03) and exposure to elevated cfPWV marginally significant (p = 0.054) in predicting greater plasma β-TG. Greater arterial stiffness, particularly central arterial stiffness, predicts greater platelet activation in overweight/obese individuals. This relationship might partly explain the association between increased arterial stiffness and incident atherothrombotic events.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23654212      PMCID: PMC3742736          DOI: 10.3109/10641963.2013.789045

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  34 in total

1.  Serum aldosterone is associated with inflammation and aortic stiffness in normotensive overweight and obese young adults.

Authors:  Jennifer N Cooper; Ping Tepper; Emma Barinas-Mitchell; Genevieve A Woodard; Kim Sutton-Tyrrell
Journal:  Clin Exp Hypertens       Date:  2011-10-18       Impact factor: 1.749

2.  The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria.

Authors:  D Ellis; C Lloyd; D J Becker; K Y Forrest; T J Orchard
Journal:  Am J Kidney Dis       Date:  1996-06       Impact factor: 8.860

3.  Association between arterial stiffness and platelet activation.

Authors:  F Yamasaki; T Furuno; K Sato; D Zhang; M Nishinaga; T Sato; Y Doi; T Sugiura
Journal:  J Hum Hypertens       Date:  2005-07       Impact factor: 3.012

4.  Forearm vascular reactivity and arterial stiffness in asymptomatic adults from the community.

Authors:  A Rauoof Malik; Venkateswarlu Kondragunta; Iftikhar J Kullo
Journal:  Hypertension       Date:  2008-04-21       Impact factor: 10.190

5.  Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients.

Authors:  Éva Csongrádi; Béla Nagy; Tibor Fulop; Zsuzsa Varga; Zsolt Karányi; Mária T Magyar; László Oláh; Mária Papp; Andrea Facskó; János Kappelmayer; György Paragh; Miklós Káplár
Journal:  Thromb Haemost       Date:  2011-08-25       Impact factor: 5.249

Review 6.  Trends in 24-h urinary sodium excretion in the United States, 1957-2003: a systematic review.

Authors:  Adam M Bernstein; Walter C Willett
Journal:  Am J Clin Nutr       Date:  2010-09-08       Impact factor: 7.045

7.  Modeling a Cross-Sectional Response Variable with Longitudinal Predictors: An Example of Pulse Pressure and Pulse Wave Velocity.

Authors:  Veena Shetty; Christopher H Morrell; Samer S Najjar
Journal:  J Appl Stat       Date:  2009-06       Impact factor: 1.404

8.  Evidence of platelet activation in hypertension.

Authors:  A D Blann; G Y Lip; I F Islim; D G Beevers
Journal:  J Hum Hypertens       Date:  1997-09       Impact factor: 3.012

9.  Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity.

Authors:  Claudia Dellas; Katrin Schäfer; Ilonka Rohm; Mareike Lankeit; Thomas Ellrott; Vivien Faustin; Joachim Riggert; Gerd Hasenfuss; Stavros Konstantinides
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

10.  Platelet and leukocyte activation, atherosclerosis and inflammation in European and South Asian men.

Authors:  O Dotsenko; N Chaturvedi; S A McG Thom; A R Wright; J Mayet; A Shore; C Schalkwijk; A D Hughes
Journal:  J Thromb Haemost       Date:  2007-10       Impact factor: 5.824

View more
  2 in total

Review 1.  Leptin as a Mediator of Obesity-Induced Hypertension.

Authors:  Balyssa B Bell; Kamal Rahmouni
Journal:  Curr Obes Rep       Date:  2016-12

2.  Modification of Platelet Count on the Association between Homocysteine and Blood Pressure: A Moderation Analysis in Chinese Hypertensive Patients.

Authors:  Jianan Zhang; Jing Li; Shi Chen; Linglin Gao; Xiaoluan Yan; Mingzhi Zhang; Jia Yu; Fenchun Wang; Hao Peng
Journal:  Int J Hypertens       Date:  2020-02-14       Impact factor: 2.420

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.